GeraldVNaccarelliMD

PubMed

• Obese patients with new onset atrial fibrillation/flutter have higher risk of hospitalization, cardioversions, and ablations.
  Djibril M Ba, Guodong Liu, Doug Leslie, Yue Zhang, Jonathan Norton, Andrew Foy, Gerald V Naccarelli> ;American Heart Journal Plus. 2024 Apr 1
• Antiarrhythmic Drug Therapy: Where Do We Go From Here?
  Peter R Kowey, Gerald V Naccarelli> ;Circulation. 2024 Mar 12
• Aggressive treatment of atrial fibrillation in hypertrophic cardiomyopathy patients improve quality of life.
  Gerald V Naccarelli, Eric D Popjes> ;Journal of Cardiovascular Electrophysiology. 2024 Apr 1
• Re-analyses of 8 Historical Trials in Cardiovascular Medicine Assessing Multimorbidity Burden and its Association with Treatment Response.
  Foy, A., Schaefer, E., Chinchilli, V., Ruzieh, M., Nudy, M., Ali, O., Naccarelli, G.> ;The American Journal of Medicine. 2024 Feb 6
• Should Patients with Subclinical Atrial Fibrillation Receive Anticoagulation?
  Reiffel, J., Kowey, P., Naccarelli, G.> ;The American Journal of Medicine. 2024 Jan 26
• Can Risk Stratification Scores Improve Selection Of Patients Who Need Primary Prevention Implantable Cardioverter-Defibrillators Or Should We Just Follow The Rules?
  Gerald V Naccarelli> ;The American Journal of Cardiology. 2024 Jan 15
• Controversies in Hypertension V: Resistant and Refractory Hypertension.
  Edward J Filippone, Gerald V Naccarelli, Andrew J Foy> ;The American Journal of Medicine. 2024 Jan 1
• Direct Oral Anticoagulants: Patients Benefit When Prescribers Get the Message.
  Gerald V Naccarelli> ;The American Journal of Cardiology. 2023 Nov 1
• Pulmonary vein isolation plus adjunctive therapy for the treatment of atrial fibrillation: a systematic review and meta-analysis.
  Rahul Bussa, Matthew Nudy, Mohammad Ahmed, Jatin Bussa, Sterling Wheaten, Eric Zimmerman, Mario D Gonzalez, Gerald V Naccarelli, Ankit Maheshwari> ;Journal of Interventional Cardiac Electrophysiology. 2024 Apr 1
• 2 citations
  Are Class IC Antiarrhythmic Agents Safe in Atrial Fibrillation Patients With Nonobstructive Coronary Artery Disease?
  Gerald V Naccarelli> ;JACC. Clinical Electrophysiology. 2023 Jul 1
• Controversies in Hypertension IV: Renal Denervation.
  Edward J Filippone, Gerald V Naccarelli, Andrew J Foy> ;The American Journal of Medicine. 2023 Sep 1
• 1 citations
  Controversies in Hypertension III: Dipping, Nocturnal Hypertension, and the Morning Surge.
  Edward J Filippone, Andrew J Foy, Gerald V Naccarelli> ;The American Journal of Medicine. 2023 Jul 1
• 1 citations
  Effect of dronedarone vs. placebo on atrial fibrillation progression: a post hoc analysis from ATHENA trial.
  Carina Blomström-Lundqvist, Gerald V Naccarelli, David S McKindley, Gregory Bigot, Mattias Wieloch, Stefan H Hohnloser> ;Europace. 2023 Mar 30
• 2 citations
  A Subgroup Meta-Analysis Comparing the Renal Denervation Sham-Controlled Randomized Trials Among Those With Resistant and Nonresistant Hypertension.
  Mohammad Ahmed, Matthew Nudy, Rahul Bussa, Gerald V Naccarelli, Edward J Filippone, Andrew J Foy> ;The American Journal of Cardiology. 2023 Mar 15
• 1 citations
  Treatment of ventricular tachycardia with catheter ablation versus anti-arrhythmic drug titration: a systematic review and meta-analysis of randomized controlled trials.
  Mohammad Ahmed, Matthew Nudy, Rahul Bussa, Mario D Gonzalez, Gerald V Naccarelli, Ankit Maheshwari> ;Journal of Interventional Cardiac Electrophysiology. 2023 Jun 1
• Should we limit antiarrhythmic drug choice in patients with left ventricular hypertrophy?
  Gerald V Naccarelli, Peter R Kowey> ;Journal of Cardiovascular Electrophysiology. 2023 Feb 1
• Cardiac Contractility Modulation Therapy: Should We Be Aiming Higher for Patients With Moderately Severe Heart Failure?
  Soraya Samii, Gerald V Naccarelli> ;Texas Heart Institute Journal. 2022 Nov 1
• 5 citations
  Non-pharmacologic autonomic neuromodulation for treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials.
  Mohammad Ahmed, Matthew Nudy, Rahul Bussa, Frank Weigel, Gerald Naccarelli, Ankit Maheshwari> ;Trends in Cardiovascular Medicine. 2024 Feb 1
• 1 citations
  Anticoagulation for atrial fibrillation using claims data - bigger is not always better.
  Gerald V Naccarelli, Mohammed Ruzieh, Kevin J Mills> ;Journal of Interventional Cardiac Electrophysiology. 2023 Apr 1
• Do class IC antiarrhythmics drugs need to be cast aside in atrial fibrillation patients with minimal coronary artery disease?
  Gerald V Naccarelli, Gregory M Burkman, Sarah K Hussain> ;Journal of Interventional Cardiac Electrophysiology. 2022 Nov 1
• 2 citations
  Understanding Antiarrhythmic Drug Efficacy for the Clinical Practitioner: There Is More than Meets the Eye.
  James A Reiffel, Gerald V Naccarelli> ;The American Journal of Medicine. 2022 Jul 1
• 5 citations
  A systematic review, meta-analysis, and meta regression of the sham controlled renal denervation randomized controlled trials.
  Mohammad Ahmed, Matthew Nudy, Rahul Bussa, Alexander Hajduczok, Gerald V Naccarelli, Edward J Filippone, Andrew J Foy> ;Trends in Cardiovascular Medicine. 2023 Nov 1
• 2 citations
  Controversies in Hypertension I: The Optimal Assessment of Blood Pressure Load and Implications for Treatment.
  Edward J Filippone, Andrew J Foy, Gerald V Naccarelli> ;The American Journal of Medicine. 2022 Sep 1
• 1 citations
  Controversies in Hypertension II: The Optimal Target Blood Pressure.
  Edward J Filippone, Andrew J Foy, Gerald V Naccarelli> ;The American Journal of Medicine. 2022 Oct 1
• 53 citations
  The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation: JACC State-of-the-Art Review.
  A John Camm, Gerald V Naccarelli, Suneet Mittal, Harry J G M Crijns, Stefan H Hohnloser, Chang-Sheng Ma, Andrea Natale, Mintu P Turakhia, Paulus Kirchhof> ;Journal of the American College of Cardiology. 2022 May 17
• Join now to see all

Journal Articles

• Original Investigation Editorial Comment Can an Intranasal Calcium-Channel Blocker Convert Paroxysmal Supraventricular Tachycardia and Keep the Doctor Away?∗  
  Mario D Gonzalez, Gerald V Naccarelli, Deborah L Wolbrette, ScienceDirect

Lectures

• Direct Oral Anticoagulant Dosing Truth or Consequences 
  Penn State Hershey College of Medicine - Continuing Education, Harrisburg, Pennsylvania - 10/3/2013
• Antiarrhythmic Drugs Are A Lost Cause 
  2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
• Electrophysiology Expert 
  2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
• Can an Intranasal Calcium-Channel Blocker Convert Paroxysmal Supraventricular Tachycardia and Keep the Doctor Away? 
  Penn State Hershey College of Medicine - Continuing Education, Harrisburg, Pennsylvania - 10/3/2013
• Join now to see all